Ondine Biomedical names Cameron Lawrence as COO, CFO

Closely-held Ondine Biomedical appointed Cameron Lawrence as chief operating officer and chief financial officer.

Mr. Lawrence previously served in positions of increasing responsibility, including CFO and later general manager and CEO of PNI Digital Media, prior to its acquisition by Staples in 2013. Prior to PNI, he served as principal financial officer of OncoGenex Pharmaceuticals, a publicly traded biopharmaceutical company.

In a statement, Carolyn Cross, Ondine’s chairman and CEO, said Mr. Lawrence brings extensive operational and financial expertise to Ondine as the company continues its trajectory as a growing biomedical company

Mr. Lawrence said Ondine is uniquely positioned to address unmet patient needs in both the infection control and chronic sinusitis markets.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.